Grief is unique for young adults with cancer

Share this article:

Grief is a unique burden for young adults with advanced cancer, and it is a burden over and above performance status, according to a recent study.

Grief is characterized by yearning for what was lost, and its symptoms include disbelief, anger, emotional numbness, and lost sense of self. Grief is distinct from depression and anxiety. Cancer can interfere with the developmental tasks of young adulthood, such as pursuing advanced education, initiating careers, and developing romantic relationships and families. This study, published in Journal of Adolescent and Young Adult Oncology, sought to examine grief due to cancer-related losses in young adults with advanced cancer.

The study enrolled 53 young adults, age 20 to 40 years, with advanced cancer. The patients completed structured clinical interviews that included measures of grief due to cancer-related losses and life disruption due to cancer symptoms. The relationship between grief and life disruption was examined by regression analyses.

Beyond the obvious physical challenges that cancer presents, this population is at risk for psychological and emotional suffering related to the many ways that advanced cancer and its treatment may interfere with their educational and career goals, early romantic relationships, parenting responsibilities, and financial and personal independence. Even those young adults who are physically functioning well may be suffering from grief and associated life disruption.

“Patients are grieving not only the effects of their cancer, but also for the life stages and transitions they would normally be experiencing as a young adult, and this article raises the importance of clinical interventions to help these patients cope with the grief associated with cancer-related losses and life disruption,” says Editor-in-Chief Leonard S. Sender, MD, University of California, Irvine and CHOC Children's Hospital.

The researchers concluded that grief is problematic for young adults with advanced cancer, and these patients may benefit from clinical assessment of and interventions for grief. The research team stated that longitudinal designs with larger data sets are needed to confirm the burden of grief in young adults with advanced cancer.
Share this article:
You must be a registered member of ONA to post a comment.

Next Article in Web Exclusives

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Genes may predict the need for further cancer treatments

A new predictive tool is being developed that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help.

Early promise from therapy targeting FGFR mutations

The investigational drug BGJ398 showed promising anticancer activity in patients with various types of cancer driven by FGFR genetic alterations.

New immunotherapy promising for advanced melanoma

A new type of immunotherapy that directs patients' immune responses toward tumor cell killing, IMCgp100, showed efficacy in some patients with advanced melanoma.